Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Dr Reddy's completes acquisition of UK co Haleon's non-US nicotine replacement therapy biz
Hyderabad-based pharma giant Dr Reddy’s Ltd finalizes its largest acquisition by buying British Haleon Plc’s non-US nicotine replacement therapy (NRT) business for GBP 458 million. The deal includes brands like Nicotinell,
Dr Reddy's completes acquisition of Haleon's NRT portfolio
Dr Reddy's Laboratories has acquired Haleon's global Nicotine Replacement Therapy (NRT) portfolio, excluding the US, for GBP 458 million. This includes top brands like Nicotinell, Nicabate, Thrive, and Habitrol,
Dr Reddy’s invests $620 million in Swiss subsidiary for Nicotinell brand acquisition
Drug maker Dr Reddy's Laboratories Ltd on Friday (September 27) said it has invested $620 million in its wholly-owned subsidiary, Dr Reddy’s Laboratories SA, Switzerland (DRL SA). This investment aligns with the company’s earlier board-approved fund infusion of up to £500 million ($640 million) to acquire the Nicotinell brand and related assets from the Haleon Group.
Dr. Reddy's Laboratories Completes $620-Million Investment In Switzerland Unit
The funds infused by the company into Dr. Reddy's SA will be used for the acquisition of Nicotinell and related brands.
Dr Reddy's Laboratories completes acquisition of Haleon's NRT portfolio
Dr Reddy's Laboratories on Monday said its Switzerland-based subsidiary has completed the acquisition of Haleon plc's global portfolio of consumer healthcare brands, outside of the US, in the Nicotine Replacement Therapy (NRT) category.
Dr Reddy's Acquires Haleon's NRT Portfolio
Dr Reddy's Laboratories has completed the acquisition of Haleon plc's global Nicotine Replacement Therapy (NRT) portfolio, including brands like Nicotinell, Nicabate, Thrive and Habitrol.
Business Line
2d
Dr Reddy’s completes acquisition of Haleon Plc’s global portfolio of consumer healthcare brands in NRT
Dr
Reddy
’s Laboratories SA, Switzerland, an arm of
Dr
Reddy
’s Laboratories, has completed the previously-announced ...
2d
Dr. Reddy's Laboratories Stocks Live Updates: Dr. Reddy's Laboratories Posts 3.03% Weekly Increase, Closing at Rs 6749.90
Stay updated with the Dr. Reddy's Laboratories Stock Liveblog, your one-stop destination for real-time information and ...
5d
Dr. Reddy's Laboratories rises Thursday, still underperforms market
Shares of Dr. Reddy's Laboratories Ltd. 500124 inched up 0.74% to 6,743.20 Indian rupees Thursday, on what proved to be an ...
The Week
1d
Dr Nilay Reddy of Hyderabad LV Prasad Eye Hospital dies in Outer Ring Road car accident
Dr. Nilay Reddy, 29, a Cornea and Anterior Segment Fellow at the LV Prasad Eye Hospital, was travelling to the airport from ...
12d
Dr. Reddy's Laboratories Share Price Today Updates: Dr. Reddy's Laboratories Sees Minor Daily Decline Amid Positive Six-Month Returns
Welcome to the Dr. Reddy's Laboratories Stock Liveblog, your ultimate source for real-time updates and analysis of one of the ...
6d
Dr. Reddy's Laboratories outperforms competitors on strong trading day
Dr. Reddy's Laboratories Ltd. 500124 shares inched up 0.64% to 6,693.65 Indian rupees Wednesday, on what proved to be an ...
5d
on MSN
Sell Dr Reddy's, Lupin, Zydus Life, Auro Pharma shares, says UBS, sees up to 20% downside
Global brokerage firm UBS has initiated coverage on as many has half dozen Indian Pharma counters and has suggested to sell ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback